NEW YORK, Feb. 18, 2016 -- The Nasdaq Stock Market® (Nasdaq:NDAQ) announced that the trading halt status in United Development Funding IV (Nasdaq:UDF) was changed to “additional information requested” from the company. Trading in the company’s stock had been halted today, February 18, 2016, at 13:33:52 Eastern Time for "news pending" at a last price of $3.20.
Trading will remain halted until United Development Funding IV has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
NDAQO
Nasdaq Media Contact: Peter Gau +1.212.231.5475 [email protected]


Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 



